PFBT
PRAX icon

Parkside Financial Bank & Trust’s Praxis Precision Medicines PRAX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.69K Hold
14
– – ﹤0.01% 1914
2026
Q1 		$4.51K Hold
14
– – ﹤0.01% 1858
2025
Q4 		$4.13K Buy
14
+4
+40% +$745 ﹤0.01% 1868
2025
Q3 		$530 Hold
10
– – ﹤0.01% 2554
2025
Q2 		$421 Hold
10
– – ﹤0.01% 2613
2025
Q1 		$379 Buy
+10
New +$625 ﹤0.01% 2569

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Parkside Financial Bank & Trust's PRAX Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 14 shares worth $4.69K. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

Parkside Financial Bank & Trust first reported a position in PRAX in Q1 2025 and has held it in 6 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Parkside Financial Bank & Trust held 14 shares of Praxis Precision Medicines worth $4.69K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1914 holding.
  • Parkside Financial Bank & Trust first reported a position in Praxis Precision Medicines in Q1 2025 and has held it in 6 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.